Report error Found 3230 Enz. Inhib. hit(s) with Target = 'C-C chemokine receptor type 2'
Affinity DataKd: 0.480nMAssay Description:Displacement of 0.1 nM [125I]CCL2 from human CCR2 expressing human U2OS cell membrane by scintillation spectrometryMore data for this Ligand-Target Pair
Affinity DataKd: 1.58E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 3.16E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.26E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 501nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 3.98E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 2.51E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 501nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 251nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 631nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+4nMAssay Description:Antagonist activity at CCR2 in human whole blood assessed as inhibition of CCL2-stimulated monocyte shape changeMore data for this Ligand-Target Pair
Affinity DataEC50: 810nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataEC50: 360nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataEC50: 810nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataEC50: 20nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataEC50: 610nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataEC50: 40nMAssay Description:Inhibition of MCP-1 induced chemotaxis in THP-1 cellsMore data for this Ligand-Target Pair
Affinity DataKd: 3.47nMAssay Description:Antagonist activity at human CCR2 in human peripheral whole blood assessed as inhibition of MCP1-induced L-selectin sheddingMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataEC50: 25nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 26nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 56nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 135nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataEC50: 30nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataEC50: 148nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 32nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as EC50 for CCL2-stimulated [35S]GTP...More data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataEC50: 54nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataEC50: 12nMAssay Description:Non-competitive insurmountable antagonist activity at human CCR2 expressed in human U2OS cell membranes assessed as pEC50 for CCL2-stimulated [35S]GT...More data for this Ligand-Target Pair
Affinity DataIC50: 0.0300nMAssay Description:Displacement of [125I]MCP1 from CCR2/CXCR4 expressed in CHOK1 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0400nMAssay Description:Displacement of [125I]SDF1alpha from CCR2/CXCR4 expressed in CHOK1 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0800nMAssay Description:Displacement of [125I]SDF1alpha from CCR2/CXCR4 expressed in CHOK1 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0900nMAssay Description:Displacement of [125I]MCP1 from CCR2/CXCR4 expressed in CHOK1 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.100nMAssay Description:Antagonist activity at human CCR2 receptor expressed in CHO cells by chemotaxis assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.100nMAssay Description:Antagonist activity at human CCR2 receptor expressed in CHO cells by chemotaxis assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.100nMAssay Description:Antagonist activity at human CCR2 receptor expressed in CHO cells by chemotaxis assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.150nMAssay Description:Inhibition of chemotaxis in human MCP1 monocytesMore data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at CCR2 in human monocytes assessed as reduction of chemotaxis in presence of 0.1 M BSAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at CCR2 in human monocytes assessed as reduction of chemotaxis in presence of 0.1 M BSAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxisMore data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Binding affinity at human CCR2 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 0.230nMAssay Description:Inhibition of chemotaxis in human MCP1 monocytesMore data for this Ligand-Target Pair
Affinity DataIC50: 0.240nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair



































3D Structure (crystal)